COLLEEN TETZLAFF: Open Payments
NPI 1144306689 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 16 payments from 7 companies in 2025. Trend: 2023 $341 · 2024 $830 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 2 | $150 |
| Janssen Biotech, Inc. | 3 | $86 |
| PFIZER INC. | 3 | $83 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: CABOMETYX, ERLEADA, XTANDI, KEYTRUDA, Vanflyta, PLUVICTO, ENHERTU, INLYTA.
Industry payments across PA — which companies pay providers there.
